VedranRadojcicMD

PubMed

• 8 citations
  Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
  Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos...> ;Journal of Clinical Oncology. 2023 Apr 1
• 19 citations
  Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
  Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung-On Yau, Rupkatha Mukhopadhyay, Benjamin Dickins, Heidi Altmann, Michael Kramer, Hann...> ;The Journal of Clinical Investigation. 2022 Nov 1
• 5 citations
  Adoptive transfer of IL-4 reprogrammed Tc17 cells elicits anti-tumour immunity through functional plasticity.
  Chiung-Hui Liu, Bo-Shiou Lin, Mei-Yao Wu, Ying-Chyi Song, Tao-Wei Ke, Yu-Lun Chou, Chuan-Teng Liu, Chia-Hsin Lin, Vedran Radojcic, Charles Drake, Hung-Rong Yen> ;Immunology. 2022 Jul 1
• 39 citations
  Signatures of GVHD and Relapse after Post-Transplant Cyclophosphamide Revealed by Immune Profiling and Machine Learning.
  Shannon R. McCurdy, Vedran Radojcic, Hua-Ling Tsai, Ante Vulic, Elizabeth D. Thompson, Sanja Ivčević, Christopher G. Kanakry, Jonathan D. Powell, Brian K. Lohman, Djam...> ;Blood. 2021 Oct 17
• 1 citations
  Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.
  Vedran Radojcic, Maria A. Pletneva, Catherine J. Lee, Sanja Ivčević, Stefanie Sarantopoulos, Daniel R. Couriel> ;British Journal of Haematology. 2021 Jun 17
• 53 citations
  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
  Daniel Wolff, Vedran Radojcic, Robert Lafyatis, Resat Cinar, Rachel K. Rosenstein, Edward W. Cowen, Guang-Shing Cheng, Ajay Sheshadri, Anne Bergeron, Kirsten M. Willia...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 21 citations
  BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
  Wei Jia, Jonathan C. Poe, Hsuan Su, Sarah Anand, Glenn K. Matsushima, Jeffrey C. Rathmell, Ivan Maillard, Vedran Radojcic, Kazuhiro Imai, Nancy J. Reyes, Diana M. Card...> ;Blood. 2021 May 6
• 2 citations
  PTCy and “The Story of the Three Bears”
  Vedran Radojcic, Leo Luznik> ;Bone Marrow Transplantation. 2021 Apr 1
• 3 citations
  PTCY keeps on giving
  Vedran Radojcic, Leo Luznik> ;Blood. 2019 Sep 12
• 9 citations
  Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease.
  Jooho Chung, Vedran Radojcic, Eric Perkey, Timothy J. Parnell, Yashar S. Niknafs, Xi Jin, Ann Friedman, Nathalie Labrecque, Bruce R. Blazar, Todd V. Brennan, Christian...> ;Journal of Immunology. 2019 Jul 15
• 10 citations
  Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye
  Vedran Radojcic, Leo Luznik> ;The Journal of Clinical Investigation. 2019 May 6
• 26 citations
  Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice
  Vedran Radojcic, Katelyn Paz, Jooho Chung, Jing Du, Eric Perkey, Ryan Flynn, Sanja Ivčević, Michael Zaiken, Ann Friedman, Minhong Yan, Maria A. Pletneva, Stefanie Sara...> ;Blood. 2018 Nov 15
• 3 citations
  Multifaceted Burden of Chronic Graft-versus-Host Disease.
  Vedran Radojcic, Catherine J. Lee, Daniel R. Couriel> ;Biology of Blood and Marrow Transplantation. 2018 Sep 1
• Notching up B-cell pathology in chronic GVHD.
  Vedran Radojcic, Leo Luznik> ;Blood. 2017 Nov 9
• 60 citations
  Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands
  Jooho Chung, Christen L. Ebens, Eric Perkey, Vedran Radojcic, Ute Koch, Leonardo Scarpellino, Alexander Tong, Frederick Allen, Sherri C. Wood, Jiane Feng, Ann Friedman...> ;The Journal of Clinical Investigation. 2017 Apr 3
• 9 citations
  Notch Signaling and Alloreactivity.
  Vedran Radojcic, Ivan Maillard> ;Transplantation. 2016 Dec 1
• 29 citations
  Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders.
  Mark Y. Chiang, Vedran Radojcic, Ivan Maillard> ;Current Opinion in Hematology. 2016 Jul 1
• 26 citations
  Transient Blockade of Delta-like Notch Ligands Prevents Allograft Rejection Mediated by Cellular and Humoral Mechanisms in a Mouse Model of Heart Transplantation
  Sherri C. Wood, Jiane Feng, Jooho Chung, Vedran Radojcic, Ashley R. Sandy-Sloat, Ann Friedman, Amy L. Shelton, Minhong Yan, Christian W. Siebel, D. Keith Bishop, Ivan ...> ;Journal of Immunology. 2015 Mar 15
• 10 citations
  The role of extracorporeal photopheresis in chronic graft-versus-host disease
  Vedran Radojcic, Maria A. Pletneva, Daniel R. Couriel> ;Transfusion and Apheresis Science. 2015 Apr 1
• 5 citations
  A Jagged Road to Lymphoma Aggressiveness
  Vedran Radojcic, Ivan Maillard> ;Cancer Cell. 2014 Mar 17
• 114 citations
  Blockade of individual Notch ligands and receptors controls graft-versus-host disease
  Ivy T. Tran, Ashley R. Sandy, Alexis J. Carulli, Christen L. Ebens, Jooho Chung, Gloria T. Shan, Vedran Radojcic, Ann Friedman, Thomas Gridley, Amy L. Shelton, Pavan R...> ;The Journal of Clinical Investigation. 2013 Apr 1
• 33 citations
  Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched ...
  Nadira Duraković, Vedran Radojcic, Anaca Boban, Mirando Mrsić, Dubravka Sertić, Ranka Serventi-Seiwerth, Damir Nemet, Boris Labar> ;Internal Medicine. 2011 Jan 1
• 74 citations
  STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model
  Vedran Radojcic, Maria A. Pletneva, Hung-Rong Yen, Sanja Ivcevic, Angela Panoskaltsis-Mortari, Anita C. Gilliam, Charles G. Drake, Bruce R. Blazar, Leo Luznik> ;Journal of Immunology. 2010 Jan 15
• 96 citations
  Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.
  Yi Zhang, Ashley R. Sandy, Jina Wang, Vedran Radojcic, Gloria T. Shan, Ivy T. Tran, Ann Friedman, Koji Kato, Shan He, Shuaiying Cui, Elizabeth O. Hexner, Dale Frank, S...> ;Blood. 2009 Nov 20
• 19 citations
  IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity
  Maria A. Pletneva, Hongni Fan, Jang-June Park, Vedran Radojcic, Chunfa Jie, Yanxing Yu, Camie Chan, Alec J. Redwood, Drew M. Pardoll, Franck Housseau> ;Cancer Research. 2009 Aug 15
• Join now to see all

Journal Articles

• Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in Mice  
  Ivan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood